Published ahead of online first Genetic analysis of therapy-related
4/04/2018 Cite this article as: Aline Renneville Philippe Attias
s reference ?origin=ppub
Reappearance of inhibitor in a tolerized patient with severe
12/05/2022 Lacroix-Desmazes Maximilien Desvages
Emicizumab does not interfere with the activated clotting time
9/01/2022 Cécile Bally5. Ahmed Abbes6. Roseline d'Oiron47. Laurent Frenzel5. Delphine Borgel1
Projet 1 : Día y Noche Artistes : Michael Hirschbichler et Guillaume
Artistes : Cécile Bally et Emma Tricard. Espace résidence : NAVE Santiago. Disciplines : danse
LISTE DE PROJETS FR
Présentation PowerPoint
5/09/2019 Aubin1 Nadia Naoui
failure syndrome and low blast count acute myeloid leukemia after
Marie Sébert Aline Renneville
A phase II study of guadecitabine in higher-risk myelodysplastic
Marie Sébert1
Dual origin of relapses in retinoic-acid resistant acute promyelocytic
24/05/2018 These authors contributed equally: Jacqueline Lehmann-Che Cécile Bally
qt r
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in
Schlageter1
e e a b b f b adf
A phase II study of guadecitabine in higher-risk myelodysplastic
Marie Sébert1
- cecile bally necker
- dr cecile bally
- bally cecyle bag